image
Cryoport, Inc. CYRX
Industrials - Integrated Freight & Logistics - NASDAQ - US
Watchlist
$ 7.0
7.77 %
$ 351 M
Market Cap
-2.82
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CYRX stock under the worst case scenario is HIDDEN Compared to the current market price of 7 USD, Cryoport, Inc. is HIDDEN

CYRX Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CYRX stock under the base case scenario is HIDDEN Compared to the current market price of 7 USD, Cryoport, Inc. is HIDDEN

CYRX Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CYRX stock under the best case scenario is HIDDEN Compared to the current market price of 7 USD, Cryoport, Inc. is HIDDEN

CYRX Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart CYRX

image
1M 4%
6M -10%
1Y -33%
3Y -288%
5Y -294%
All
$9.0$9.0$8.5$8.5$8.0$8.0$7.5$7.5$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.515 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
228 M REVENUE
-2.09%
Growth Rates
1Year -2.09%
3Years 0.86%
5Years 46.42%
7Years 52.41%
10Years 50.10%
-131 M OPERATING INCOME
-13.64%
Growth Rates
1Year -13.64%
3Years -94.34%
5Years -49.24%
7Years -49.36%
10Years -37.06%
-115 M NET INCOME
-15.23%
Growth Rates
1Year -15.23%
3Years 25.32%
5Years -44.32%
7Years -46.56%
10Years -32.22%
-16.3 M OPERATING CASH FLOW
-2056.27%
Growth Rates
1Year -2056.27%
3Years -44.36%
5Years -65.27%
7Years -24.19%
10Years -14.74%
177 M INVESTING CASH FLOW
390.54%
Growth Rates
1Year 390.54%
3Years 33.45%
5Years 36.91%
7Years 93.12%
10Years 118.87%
-162 M FINANCING CASH FLOW
-578.76%
Growth Rates
1Year -578.76%
3Years -8.75%
5Years -26.02%
7Years -41.14%
10Years -41.36%
41 M REVENUE
-31.06%
Growth Rates
1Year -2.09%
3Years 0.86%
5Years 46.42%
7Years 52.41%
10Years 50.10%
-9.48 M OPERATING INCOME
31.92%
Growth Rates
1Year -13.64%
3Years -94.34%
5Years -49.24%
7Years -49.36%
10Years -37.06%
-14 M NET INCOME
100.00%
Growth Rates
1Year -15.23%
3Years 25.32%
5Years -44.32%
7Years -46.56%
10Years -32.22%
0 OPERATING CASH FLOW
100.00%
Growth Rates
1Year -2056.27%
3Years -44.36%
5Years -65.27%
7Years -24.19%
10Years -14.74%
5.92 M INVESTING CASH FLOW
70.22%
Growth Rates
1Year 390.54%
3Years 33.45%
5Years 36.91%
7Years 93.12%
10Years 118.87%
-189 K FINANCING CASH FLOW
-9.39%
Growth Rates
1Year -578.76%
3Years -8.75%
5Years -26.02%
7Years -41.14%
10Years -41.36%
Balance Sheet Cryoport, Inc.
image
Current Assets 342 M
Cash & Short-Term Investments 262 M
Receivables 45.8 M
Other Current Assets 34 M
Non-Current Assets 362 M
Long-Term Investments 0
PP&E 136 M
Other Non-Current Assets 226 M
37.21 %6.51 %4.84 %19.34 %32.11 %Total Assets$703.5m
Current Liabilities 64.6 M
Accounts Payable 27.2 M
Short-Term Debt 14.4 M
Other Current Liabilities 22.9 M
Non-Current Liabilities 237 M
Long-Term Debt 230 M
Other Non-Current Liabilities 6.68 M
9.02 %4.79 %7.60 %76.38 %Total Liabilities$301.6m
EFFICIENCY
Earnings Waterfall Cryoport, Inc.
image
Revenue 228 M
Cost Of Revenue 129 M
Gross Profit 99.6 M
Operating Expenses 230 M
Operating Income -131 M
Other Expenses -16.1 M
Net Income -115 M
250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)(150m)(150m)228m(129m)100m(230m)(131m)16m(115m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
43.62% GROSS MARGIN
43.62%
Averages
1Year 43.62%
3Years 43.33%
5Years 43.91%
7Years 46.12%
10Years 44.53%
-57.30% OPERATING MARGIN
-57.30%
Averages
1Year -57.30%
3Years -40.04%
5Years -33.25%
7Years -37.48%
10Years -59.12%
-50.25% NET MARGIN
-50.25%
Averages
1Year -50.25%
3Years -36.23%
5Years -54.80%
7Years -53.81%
10Years -78.05%
-28.55% ROE
-28.55%
Averages
1Year -28.55%
3Years -18.54%
5Years -21.42%
7Years -20.92%
10Years -73.86%
-16.31% ROA
-16.31%
Averages
1Year -16.31%
3Years -10.10%
5Years -12.20%
7Years -13.05%
10Years -46.06%
-20.25% ROIC
-20.25%
Averages
1Year -20.25%
3Years -12.07%
5Years -8.72%
7Years -10.47%
10Years -46.75%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cryoport, Inc.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)(30m)(30m)(35m)(35m)(40m)(40m)(45m)(45m)(50m)(50m)201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -115 M
Depreciation & Amortization 30.8 M
Capital Expenditures -17.3 M
Stock-Based Compensation 19.7 M
Change in Working Capital 0
Others 56.6 M
Free Cash Flow -33.6 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cryoport, Inc.
image
Wall Street analysts predict an average 1-year price target for CYRX of $11 , with forecasts ranging from a low of $8 to a high of $15 .
CYRX Lowest Price Target Wall Street Target
8 USD 14.29%
CYRX Average Price Target Wall Street Target
11 USD 57.14%
CYRX Highest Price Target Wall Street Target
15 USD 114.29%
Price
Max Price Target
Min Price Target
Average Price Target
1616141412121010886644Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 4
6. Ownership
Insider Ownership Cryoport, Inc.
image
Sold
0-3 MONTHS
114 K USD 4
3-6 MONTHS
94.1 K USD 4
6-9 MONTHS
1.55 M USD 3
9-12 MONTHS
60.4 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Wall Street Analysts Believe CryoPort (CYRX) Could Rally 81.43%: Here's is How to Trade The average of price targets set by Wall Street analysts indicates a potential upside of 81.4% in CryoPort (CYRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com - 3 weeks ago
Does CryoPort (CYRX) Have the Potential to Rally 54.74% as Wall Street Analysts Expect? The mean of analysts' price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com - 1 month ago
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript Cryoport, Inc. (NASDAQ:CYRX ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Kyle Crews - UBS Richard Baldry - ROTH Capital David Larsen - BTIG Subbu Nambi - Guggenheim Securities Matt Stanton - Jefferies Anna Snopkowski - KeyBanc Operator Good afternoon, and welcome to Cryoport's First Quarter 2025 Earnings Call. All participants will start in a listen-only mode. seekingalpha.com - 1 month ago
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.43 per share a year ago. zacks.com - 1 month ago
Cryoport Reports First Quarter 2025 Financial Results Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over year Q1 2025 revenue from continuing operations of $41.0 million, up 10% year over year Supporting 711 global clinical trials as of March 31, 2025 Strategic partnership with DHL; CRYOPDP divestiture expected to close Q2/Q3 2025 NASHVILLE, Tenn. , May 7, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global provider of temperature-controlled supply chain solutions for the life sciences sector, today announced financial results for the first quarter (Q1) ended March 31, 2025. prnewswire.com - 1 month ago
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Should You Buy? CryoPort (CYRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 month ago
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025 NASHVILLE, Tenn. , April 24, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global provider of supply chain solutions for the life sciences sector, today announced that the Company will report financial results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 after U.S. markets close. prnewswire.com - 1 month ago
Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript) Cryoport, Inc. (NASDAQ:CYRX ) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ET Company Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Tom Heinzen - Vice President, Corporate Development & Investor Relations Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Conference Call Participants Puneet Souda - Leerink Partners Subbu Nambi - Guggenheim Paul Knight - KeyBanc Tejas Savant - Morgan Stanley David Larsen - BTIG David Saxon - Needham Operator Good morning, and welcome to Cryoport's Investor Conference Call. All participants will start in a listen-only mode. seekingalpha.com - 2 months ago
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics" DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in specialty pharma logistics and supports Group's 2030 strategy to become a leader in life science and healthcare logistics. prnewswire.com - 2 months ago
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET NASHVILLE, Tenn. , March 31, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences sector, today announced that the Company will host an investor call today, Monday, March 31, 2025, at 8:30 a.m. prnewswire.com - 2 months ago
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories NASHVILLE, Tenn. , March 12, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency ("HE") Series of cryogenic freezers. prnewswire.com - 3 months ago
Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript Start Time: 17:00 January 1, 0000 5:41 PM ET Cryoport, Inc. (NASDAQ:CYRX ) Q4 2024 Earnings Conference Call March 04, 2025, 17:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Anna Snopkowski - KeyBanc Capital Markets Puneet Souda - Leerink Partners David Saxon - Needham Subbu Nambi - Guggenheim David Larson - BTIG Richard Baldry - Roth Capital Kyle Crews - UBS Matt Stanton - Jefferies Operator Good afternoon, and welcome to Cryoport's Fourth Quarter and Full Year 2024 Earnings Conference Call. All participants will start in a listen-only mode. seekingalpha.com - 3 months ago
8. Profile Summary

Cryoport, Inc. CYRX

image
COUNTRY US
INDUSTRY Integrated Freight & Logistics
MARKET CAP $ 351 M
Dividend Yield 0.00%
Description Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
Contact 112 Westwood Place, Brentwood, TN, 37027 https://www.cryoport.com
IPO Date Aug. 22, 2005
Employees 1090
Officers Mr. Edward J. Zecchini Senior Vice President and Chief Digital & Technology Officer Mr. Tony Ippolito Vice President, General Counsel & Corporate Secretary Mr. Jerrell W. Shelton Chairman, President & Chief Executive Officer Mr. Phil Wilson Chief Operating Officer of Cryoport Systems, LLC Ms. Kylie A. Crowe Vice President of Global Human Resources & Organizational Development Mr. Robert S. Stefanovich MS Senior Vice President, Chief Financial Officer, Treasurer & Chief Administrative Officer Dr. Mark W. Sawicki Ph.D. Senior Vice President & Chief Scientific Officer Mr. Thomas J. Heinzen Vice President of Corporate Development & Investor Relations